159 related articles for article (PubMed ID: 8985326)
1. Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi.
Gao Y; Smith PR; Karran L; Lu QL; Griffin BE
J Virol; 1997 Jan; 71(1):84-94. PubMed ID: 8985326
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.
Gao Y; Xue Sa; Griffin BE
Mol Cell Biol; 1999 Nov; 19(11):7305-13. PubMed ID: 10523619
[TBL] [Abstract][Full Text] [Related]
3. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
[TBL] [Abstract][Full Text] [Related]
7. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
8. Expression of two related viral early genes in Epstein-Barr virus-associated tumors.
Xue SA; Lu QL; Poulsom R; Karran L; Jones MD; Griffin BE
J Virol; 2000 Mar; 74(6):2793-803. PubMed ID: 10684296
[TBL] [Abstract][Full Text] [Related]
9. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.
Jones MD; Foster L; Sheedy T; Griffin BE
EMBO J; 1984 Apr; 3(4):813-21. PubMed ID: 6327290
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing determines the carboxy terminus of the Epstein-Barr virus nuclear antigen 5 species expressed in the Burkitt's lymphoma cell line Daudi.
Ring CJ; Jones MD; Griffin BE
J Gen Virol; 1992 Oct; 73 ( Pt 10)():2715-9. PubMed ID: 1328484
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.
Clarke PA; Sharp NA; Arrand JR; Clemens MJ
Biochim Biophys Acta; 1990 Aug; 1050(1-3):167-73. PubMed ID: 2169891
[TBL] [Abstract][Full Text] [Related]
12. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
14. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
15. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines.
Touitou R; Arbach H; Cochet C; Feuillard J; Martin A; Raphaël M; Joab I
J Gen Virol; 2003 Apr; 84(Pt 4):949-957. PubMed ID: 12655096
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
[TBL] [Abstract][Full Text] [Related]
19. Expression of genes for the Epstein-Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt's lymphoma cells: effects of interferon treatment.
Clarke PA; Sharp NA; Clemens MJ
J Gen Virol; 1992 Dec; 73 ( Pt 12)():3169-75. PubMed ID: 1335024
[TBL] [Abstract][Full Text] [Related]
20. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
